#United States #St. Louis #Centene Corporation #Paul Diaz #Kenneth Burdick

Centene Corporation Welcomes New Board Member

On July 28, 2026, Centene Corporation (NYSE: CNC) made headlines as it announced a pivotal change in its Board of Directors. Kenneth A. Burdick, who has served on the board since January 2022, is retiring, making way for Paul J. Diaz, who brings a wealth of healthcare experience.

Overview of Kenneth A. Burdick's Tenure

Mr. Burdick, during his tenure at Centene, significantly impacted the organization with his extensive background in the healthcare sector. He previously held several key positions within the company, including Executive Vice President of Products and Markets, and he also served as CEO of WellCare Health Plans. His leadership was marked by strategic insights that greatly benefited the company's mission to improve community health.

Reflecting on his time at Centene, Burdick expressed gratitude for the opportunity to serve and emphasized the company's strong foundation for future growth. He stated, "It has been a privilege to serve Centene and support its mission of transforming the health of the communities it serves, one person at a time."

Welcoming Paul J. Diaz to the Board

As Burdick steps down, Paul J. Diaz steps into the role, effective the same day. Diaz's impressive resume includes being the Managing Partner at Cressey & Company, a private investment firm focused on healthcare, and previous leadership roles as President and CEO of Myriad Genetics and Kindred Healthcare. His rich background offers Centene valuable perspectives and strategic insights, especially at a time when healthcare innovation is paramount.

Mr. Diaz expressed his honor in joining the board and mentioned his commitment to advancing Centene's mission. He stated, "I am honored to join Centene's Board of Directors and support a company with such a strong mission and commitment to improving the health of the communities it serves."

Impact on Centene Corporation’s Future

These board changes come at a crucial time for Centene Corporation, which is recognized as a leading healthcare enterprise committed to helping individuals lead healthier lives. The company primarily provides government-sponsored and commercial healthcare services with a focus on under-insured individuals.

Under the leadership of its board, Centene is well-positioned to navigate future challenges and capitalize on emerging opportunities within the healthcare landscape. The company serves over 15 million Americans, including Medicaid and Medicare members, as well as those benefiting from Health Insurance Marketplace plans.

Conclusion

As Centene Corporation continues to innovate and expand its offerings, the addition of Paul Diaz to the Board of Directors signals a strategic step toward enhancing governance and leadership. The company remains focused on its commitment to transform healthcare through quality and accessible services.